mevdev

Home/Alex Natskovich

About Alex Natskovich

This author has not yet filled in any details.
So far Alex Natskovich has created 110 blog entries.

Commentary: The Challenges of Harmonizing Biomarker Data: Why Trial Success Depends on It

By | 2017-03-21T05:43:03+00:00 February 21st, 2017|Categories: THOUGHT LEADERSHIP|

Precision for Medicine’s Scott Marshall and Jared Kohler address the challenges and importance of harmonizing biomarker data in a new editorial for Genetic Engineering and Biotechnology News (GEN). Scott and Jared make the point that generating, tracking, and harmonizing biomarker data and clinical data in real time to inform timely decision-making is critical in modern clinical trials.

Download the New Oncology Research Brief from Precision Health Economics

By | 2017-03-22T08:23:49+00:00 February 17th, 2017|Categories: THOUGHT LEADERSHIP|

How is value defined in cancer care? What do patients value most? As healthcare spending continues to rise, payers and providers struggle to accurately measure value to patients, and with health systems all over the world shifting towards paying for value, not just volume, these efforts have never been more important.

Jeremy Schafer Addresses Sanofi/Regeneron’s dupilumab in BioPharm Insight

By | 2017-03-16T06:22:50+00:00 February 17th, 2017|Categories: News|

Precision for Value’s Jeremy Schafer comments on pricing and reimbursement of dupilumab, Sanofi/Regeneron’s first atopic dermatitis biologic, in BioPharm Insight.

Precision for Value’s Hepatitis C Survey Discussed in Managed Healthcare Executive: Here’s What’s Missing

By | 2017-03-20T04:34:07+00:00 February 17th, 2017|Categories: News|

Precision for Value’s Jeremy Schafer highlights what can be done to encourage payers to ease coverage policies for these drugs in the next wave of HCV treatment.

NCQA’s HEDIS® Data Now Incorporated Into Precision for Value’s Qnav® Tool

By | 2017-03-07T12:01:21+00:00 February 8th, 2017|Categories: News, Press Releases|

Life Sciences Companies Now Given Unprecedented Access and Visualization of Quality Performance Data JOINT PRESS RELEASE February 8, 2017 – New York, NY – Life sciences companies stand to be the primary beneficiary of a unique license agreement that integrates the industry’s most robust quality performance data available into a single tool. Precision for Value (PFV) has [...]

Precision for Value’s Maureen Hennessey Appointed to NQF’s Medicaid Innovation Accelerator Project

By | 2017-03-07T12:00:37+00:00 February 2nd, 2017|Categories: News, Press Releases|

Quality and Population Health Expert to Serve on Coordinating Committee and Chair Physical and Mental Health Technical Expert Panel  February 2, 2017 – New York, NY – Precision for Value, the market leader supporting global pharmaceutical companies in demonstrating the value of innovative medical products, today announced that Maureen Hennessey, SVP, Director, Quality and Population Health Systems, [...]